PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis

By Sokoll L.J.   Chan D.W.   Mikolajczyk S.D.   Rittenhouse H.G.   Evans C.L.   Linton H.J.   Mangold L.A.   Mohr P.   Bartsch G.   Klocker H.   Horninger W.   Partin A.W.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 274-276

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

By Elabbady Ahmed   Khedr Mahrousa  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite

The utility of free/total PSA ratios in the detection of high gleason grade prostate cancer in a cohort of prospectively screened young men with a total PSA of 4 to 10 ng/ml

By Rowe E.   Patel A.   Walker M.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 77-77

Elsevier

Access to resources Recommend Favorite

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

By Djavan B.   Zlotta A.   Kratzik C.   Remzi M.   Seitz C.   Schulman C.C.   Marberger M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite